157 related articles for article (PubMed ID: 27358845)
1. Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins.
Furuya Y; Sekine Y; Kato H; Miyazawa Y; Koike H; Suzuki K
Prostate Int; 2016 Jun; 4(2):56-60. PubMed ID: 27358845
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism.
Sekine Y; Nakayama H; Miyazawa Y; Kato H; Furuya Y; Arai S; Koike H; Matsui H; Shibata Y; Ito K; Suzuki K
Oncol Lett; 2018 Mar; 15(3):3167-3172. PubMed ID: 29435052
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells
Oka D; Sekine Y; Tsuji Y; Nakayama H; Miyazawa Y; Arai S; Koike H; Suzuki K
Anticancer Res; 2024 Jan; 44(1):93-98. PubMed ID: 38159995
[TBL] [Abstract][Full Text] [Related]
5. Effect of simvastatin on castration-resistant prostate cancer cells.
Kim JH; Cox ME; Wasan KM
Lipids Health Dis; 2014 Mar; 13():56. PubMed ID: 24666612
[TBL] [Abstract][Full Text] [Related]
6. The effects of metformin and simvastatin on the growth of LNCaP and RWPE-1 prostate epithelial cell lines.
Pennanen P; Syvälä H; Bläuer M; Savinainen K; Ylikomi T; Tammela TLJ; Murtola TJ
Eur J Pharmacol; 2016 Oct; 788():160-167. PubMed ID: 27341997
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL.
Murtola TJ; Syvälä H; Pennanen P; Bläuer M; Solakivi T; Ylikomi T; Tammela TL
Eur J Pharmacol; 2011 Dec; 673(1-3):96-100. PubMed ID: 22040920
[TBL] [Abstract][Full Text] [Related]
8. RP1-13D10.2 Is a Novel Modulator of Statin-Induced Changes in Cholesterol.
Mitchel K; Theusch E; Cubitt C; Dosé AC; Stevens K; Naidoo D; Medina MW
Circ Cardiovasc Genet; 2016 Jun; 9(3):223-30. PubMed ID: 27071970
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells.
Miyazawa Y; Sekine Y; Oka D; Nakazawa S; Tsuji Y; Nakayama H; Suzuki K
Anticancer Res; 2023 Dec; 43(12):5377-5386. PubMed ID: 38030198
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics and regulatory mechanisms of lipid metabolism remodeling after malignant transformation of glioma-associated macrophages].
Sheng YJ; Jiang QQ; Liu L; Cheng S; Li HR; Li SW; Huang SL; Li YD; Yuan JQ; Ping YF; Dong J
Zhonghua Yi Xue Za Zhi; 2022 Oct; 102(39):3134-3142. PubMed ID: 36274598
[No Abstract] [Full Text] [Related]
11. Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.
Masko EM; Alfaqih MA; Solomon KR; Barry WT; Newgard CB; Muehlbauer MJ; Valilis NA; Phillips TE; Poulton SH; Freedland AR; Sun S; Dambal SK; Sanders SE; Macias E; Freeman MR; Dewhirst MW; Pizzo SV; Freedland SJ
Prostate; 2017 Apr; 77(5):446-457. PubMed ID: 27900797
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor.
Sekine Y; Furuya Y; Nishii M; Koike H; Matsui H; Suzuki K
Biochem Biophys Res Commun; 2008 Jul; 372(2):356-61. PubMed ID: 18489904
[TBL] [Abstract][Full Text] [Related]
14. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways.
Kotamraju S; Williams CL; Kalyanaraman B
Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor (NGF) and pro-NGF increase low-density lipoprotein (LDL) receptors in neuronal cells partly by different mechanisms: role of LDL in neurite outgrowth.
Do HT; Bruelle C; Pham DD; Jauhiainen M; Eriksson O; Korhonen LT; Lindholm D
J Neurochem; 2016 Jan; 136(2):306-15. PubMed ID: 26484803
[TBL] [Abstract][Full Text] [Related]
16. The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial.
Feldt M; Menard J; Rosendahl AH; Lettiero B; Bendahl PO; Belting M; Borgquist S
Cancer Metab; 2020 Nov; 8(1):25. PubMed ID: 33292612
[TBL] [Abstract][Full Text] [Related]
17. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
[TBL] [Abstract][Full Text] [Related]
18. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
Hoque A; Chen H; Xu XC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
[TBL] [Abstract][Full Text] [Related]
19. A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer.
Sun Q; Arnold RS; Sun CQ; Petros JA
Prostate; 2015 Dec; 75(16):1916-25. PubMed ID: 26383260
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
